跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
張 宜崴
助理教授
,
病理學科
主治醫師
,
臺北市立萬芳醫院
https://orcid.org/0000-0003-3334-3088
電子郵件
b8701079
tmu.edu
tw
,
108098
w.tmu.edu
tw
h-index
946
引文
18
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2009
2024
每年研究成果
概覽
指紋
網路
專案
(3)
研究成果
(81)
類似的個人檔案
(6)
指紋
查看啟用 I-Wei Chang 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Neoplasm
100%
Squamous Cell
45%
Transitional Cell Carcinoma
42%
Upper Urinary Tract
42%
Rectum Cancer
38%
Bladder
38%
Radiofrequency Ablation
36%
Chemoradiotherapy
35%
Disease Specific Survival
32%
Nasopharynx Carcinoma
30%
Prognostic Factor
30%
Metastasis Free Survival
27%
Nonalcoholic Fatty Liver
24%
Biological Marker
21%
Local Recurrence Free Survival
20%
Protein Expression
19%
Recurrent Disease
19%
Immunohistochemistry
18%
Metastatic Carcinoma
17%
Disease
16%
Liver Fibrosis
15%
Multivariate Analysis
13%
Tumor Regression
13%
Endoscopic Submucosal Dissection
13%
Hazard Ratio
12%
DNA Methyltransferase
12%
Esophageal Squamous Cell Carcinoma
12%
Morbid Obesity
12%
Tumor Progression
12%
Univariate Analysis
11%
Fibrosis
11%
Immunoreactivity
10%
Primary Tumor
9%
Upregulation
9%
Rectum Carcinoma
8%
Thrombospondin 2
8%
Malignant Neoplasm
8%
Transaminase
8%
Endoscopic Surgery
7%
Adverse Event
7%
Transcriptomics
7%
Biopsy
7%
Distant Metastasis Free Survival
6%
Clear Cell Renal Cell Carcinoma
6%
Alanine Aminotransferase
6%
Diagnosis
6%
Esophageal Stricture
6%
Tumor Invasion
6%
Transcriptome
6%
Surgery
6%
Pharmacology, Toxicology and Pharmaceutical Science
Chemoradiation Therapy
48%
Rectum Cancer
44%
Transitional Cell Carcinoma
30%
Disease Specific Survival
26%
Metastasis Free Survival
24%
Neoplasm
22%
Local Recurrence Free Survival
19%
Nasopharynx Carcinoma
18%
Nonalcoholic Fatty Liver
18%
Biological Marker
18%
Tumor Regression
16%
Liver Fibrosis
14%
Esophageal Squamous Cell Carcinoma
12%
Morbid Obesity
12%
Tumor Growth
12%
Fibrosis
10%
Placebo
9%
Tenofovir Disoproxil
9%
Rectum Carcinoma
8%
Thrombospondin 2
8%
Aminotransferase
8%
Disease Free Survival
7%
Recurrent Disease
7%
Malignant Neoplasm
7%
Carcinogenesis
6%
Distant Metastasis Free Survival
6%
Primary Tumor
6%
Hepatitis B Virus
6%
Alanine Aminotransferase
6%
Synapsin I
6%
Renal Cell Carcinoma
6%
Scutellaria barbata
6%
Fibronectin
6%
Glutathione Peroxidase 2
6%
Endothelin Converting Enzyme
6%
Gliosarcoma
6%
Necdin
6%
Fructose Bisphosphate Aldolase
6%
Chronic Hepatitis B
6%
DNA Methyltransferase
6%
6 O Methylguanine
6%
Acinetobacter Infection
6%
Lung Infection
6%
Lymphadenopathy
6%
Carbamoyl Phosphate Synthase
6%
Bile Duct Carcinoma
6%
Cerebellar Ataxia
6%
Horseshoe Kidney
6%
Nerve Growth Factor
6%
Epidermal Growth Factor Receptor
6%
Biochemistry, Genetics and Molecular Biology
Disease Specific Survival
49%
Metastasis Free Survival
47%
Local Recurrence Free Survival
36%
Multivariate Analysis
16%
Tumor Progression
15%
Protein Expression
14%
Disease Free Survival
13%
Transcriptomics
10%
Distant Metastasis Free Survival
8%
Gene Expression
8%
Overall Survival
7%
Upregulation
7%
Immunostaining
7%
Transcriptome
6%
Quantitative Reverse Transcription Polymerase Chain Reaction
6%
Cell Cycle
6%
Dipeptidyl Peptidase-4
6%
Aldolase B
6%
Necdin
6%
Lipid Biosynthesis
6%
Amino Acids
6%
Protein Folding
6%
Mesenchymal-Epithelial Transition
6%
Carbamoyl Phosphate Synthetase I
6%
Glutamate Decarboxylase
6%
Hyaluronan Synthase
6%
Urea Cycle
6%
Janus Kinase
6%
Cell Growth
6%
Eicosanoid Receptor
6%
Ephrin Receptor
6%
Transaminase
6%
Carcinogenesis
6%
Survival Index
5%
Cancer Cell
5%
